Chien Te K. Tseng focuses on Coronavirus, Virology, Immunology, Virus and Innate immune system. Chien Te K. Tseng interconnects Autoimmunity, Gene expression and T-cell receptor in the investigation of issues within Virology. In general Immunology, his work in Pathogenesis and Viral replication is often linked to Middle East respiratory syndrome coronavirus linking many areas of study.
In the field of Virus, his study on Hepatitis C virus and CD81 overlaps with subjects such as Tetraspanin and Co-stimulation. His Innate immune system study combines topics in areas such as Dendritic cell, Respiratory epithelium, CD40 and Monocyte. His Neutralizing antibody research integrates issues from Immunopathology and Vaccination.
Virology, Coronavirus, Antibody, Immunology and Virus are his primary areas of study. His research integrates issues of Adjuvant and Immune system in his study of Virology. His Coronavirus study frequently draws connections between adjacent fields such as Coronaviridae.
His Neutralization and Antigenicity study in the realm of Antibody connects with subjects such as Severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome. The study of Immunology is intertwined with the study of Genetically modified mouse in a number of ways. His research in Virus intersects with topics in Interferon, Transcription factor, Gene expression and Drug.
His primary areas of study are Virology, Antibody, Virus, In vitro and Coronavirus. Chien Te K. Tseng is involved in the study of Virology that focuses on Neutralizing antibody in particular. The various areas that Chien Te K. Tseng examines in his Antibody study include Immune system, Viral load and Fusion protein.
His Immune system research incorporates elements of Antigen and Vaccination. He works mostly in the field of Virus, limiting it down to concerns involving Genetically modified mouse and, occasionally, Immunology, Pathogenesis and Lung injury. Many of his studies on Coronavirus involve topics that are commonly interrelated, such as Pandemic.
His main research concerns Virology, Coronavirus, Antibody, Protein domain and Pandemic. His Virology research is multidisciplinary, incorporating elements of Protein structure and Fusion protein. Throughout his Coronavirus studies, he incorporates elements of other sciences such as Plaque reduction neutralization test, Ledipasvir, Inhibitory postsynaptic potential, Peptide and Peptide sequence.
His study on Immunoglobulin G and Immunogenicity is often connected to Middle East respiratory syndrome coronavirus as part of broader study in Antibody. The study incorporates disciplines such as Cell culture, Neutralization, Mutant, Bivalent and Glycoprotein in addition to Protein domain. His Pandemic study frequently links to other fields, such as Severe acute respiratory syndrome coronavirus 2.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
Chien Te Tseng;Elena Sbrana;Naoko Iwata-Yoshikawa;Patrick C. Newman.
PLOS ONE (2012)
Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions
Chien Te K. Tseng;Gary R. Klimpel.
Journal of Experimental Medicine (2002)
Animal models for COVID-19.
César Muñoz-Fontela;William E. Dowling;Simon G.P. Funnell;Pierre S. Gsell.
Nature (2020)
Severe Acute Respiratory Syndrome Coronavirus nsp1 Suppresses Host Gene Expression, Including That of Type I Interferon, in Infected Cells
Krishna Narayanan;Cheng Huang;Kumari Lokugamage;Wataru Kamitani.
Journal of Virology (2008)
Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus *
Santhana G. Devaraj;Nan Wang;Zhongbin Chen;Zihong Chen.
Journal of Biological Chemistry (2007)
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
Shuai Xia;Lei Yan;Wei Xu;Anurodh Shankar Agrawal.
Science Advances (2019)
Severe Acute Respiratory Syndrome (SARS) Coronavirus-Induced Lung Epithelial Cytokines Exacerbate SARS Pathogenesis by Modulating Intrinsic Functions of Monocyte-Derived Macrophages and Dendritic Cells
Tomoki Yoshikawa;Terence Hill;Kui Li;Clarence J. Peters.
Journal of Virology (2009)
Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus.
Anurodh Shankar Agrawal;Xinrong Tao;Abdullah Algaissi;Abdullah Algaissi;Tania Garron.
Human Vaccines & Immunotherapeutics (2016)
Severe Acute Respiratory Syndrome Coronavirus Infection of Mice Transgenic for the Human Angiotensin-Converting Enzyme 2 Virus Receptor
Chien Te K. Tseng;Cheng Huang;Patrick Newman;Nan Wang.
Journal of Virology (2007)
Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.
Yoshikazu Honda-Okubo;Dale Barnard;Chun Hao Ong;Bi Hung Peng.
Journal of Virology (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Fudan University
Georgia State University
The University of Texas Medical Branch at Galveston
The University of Texas Medical Branch at Galveston
Zhengzhou University
Baylor College of Medicine
Baylor College of Medicine
University of Pittsburgh
University of Iowa
New York Blood Center
University of Virginia
University of Washington
University of Central Florida
University of Castilla-La Mancha
Tokyo Institute of Technology
Queen's University Belfast
University College London
Durham University
University of Oxford
Huntsman Cancer Institute
Case Western Reserve University
Medical University of Vienna
Kyushu University
University of Wisconsin–Madison
Rutgers, The State University of New Jersey
Technion – Israel Institute of Technology